Cell-penetrating peptides for drug delivery across membrane barriers (Q37039034)

17 August 2017

1 reference

title

Cell-penetrating peptides for drug delivery across membrane barriers (English)

1 reference

17 August 2017

1 reference

Camilla Foged

1

1 reference

PubMed ID

18095931

17 August 2017

Hanne Moerck Nielsen

series ordinal

2

1 reference

PubMed ID

18095931

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Drug Delivery

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

1

1 reference

17 August 2017

105-117

1 reference

Cellular uptake of the tat protein from human immunodeficiency virus

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Antennapedia homeobox peptide regulates neural morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Tat-mediated delivery of heterologous proteins into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell-penetrating peptides: mechanism and kinetics of cargo delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell penetrating peptides in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

A peptide carrier for the delivery of biologically active proteins into mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

The antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Evidence that membrane transduction of oligoarginine does not require vesicle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Direct observation of anion-mediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Arginine magic with new counterions up the sleeve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Peptide degradation is a critical determinant for cell-penetrating peptide uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Biophysical and biological studies of end-group-modified derivatives of Pep-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Quantification of the efficiency of cargo delivery by peptidic and pseudo-peptidic Trojan carriers using MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

In vitro uptake and stability study of pVEC and its all-D analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Developing novel hCT derived cell-penetrating peptides with improved metabolic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cargo delivery kinetics of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell-penetrating peptides: a comparative membrane toxicity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Protein delivery by the cell-penetrating peptide YTA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Characterisation of cell-penetrating peptide-mediated peptide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective methods to improve inhibition of mitochondria-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell-permeable peptides induce dose- and length-dependent cytotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Protein transduction: cell penetrating peptides and their therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Doxorubicin-peptide conjugates overcome multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell-penetrating peptides: mechanisms and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Protein transduction domains and their utility in gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Peptide-guided gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Evaluation of transportan 10 in PEI mediated plasmid delivery assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Macro-branched cell-penetrating peptide design for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Octaarginine-modified multifunctional envelope-type nano device for siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Tatp-mediated intracellular delivery of pharmaceutical nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Transport of surface-modified nanoparticles through cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Passage of cell-penetrating peptides across a human epithelial cell layer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Transdermal protein delivery by a coadministered peptide identified via phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Interaction of S413-PV cell penetrating peptide with model membranes: relevance to peptide translocation across biological membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

A Comprehensive Model for the Cellular Uptake of Cationic Cell-penetrating Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.1.105

21 January 2018

Identifiers

DOI

10.1517/17425247.5.1.105

1 reference

17 August 2017

1 reference

PubMed ID

18095931